Avadel
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Ireland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10 Earlsfort Ter, Dublin, Leinster, D02 ...Phone Number
+353 19015201Website
www.avadel.comRevenue
$248.5 MillionStock Symbol
AVDLIndustry
About Avadel
Avadel Pharmaceuticals is an Irish‑headquartered specialty biopharmaceutical company that focuses on developing and commercializing innovative medicines to address unmet needs in sleep medicine and related neurological conditions. Originally founded in France and later based in Dublin, the organization has built its reputation around advancing treatments that improve the lives of patients affected by chronic sleep disorders, most notably through its lead product LUMRYZ, an extended‑release therapy approved for conditions related to narcolepsy and excessive daytime sleepiness. The company’s work reflects a deep commitment to transforming treatment paradigms where traditional options have been limited, combining scientific expertise with a patient‑centric approach to medicine development and delivery.Explore more
Avadel Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Avadel Tech Stack
A closer look at the technologies used by Avadel
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Avadel
Sign Up For FreeTo access detailed company insights
Avadel Pharmaceuticals is an Irish‑headquartered specialty biopharmaceutical company that focuses on developing and commercializing innovative medicines to address unmet needs in sleep medicine and related neurological conditions. Originally founded in France and later based in Dublin, the organization has built its reputation around advancing trea... Read More
